PLUS1
0.42
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Premarket
| Volume | 21 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Stock Name | Stock Symbol | Market | Stock Type |
|---|---|---|---|
| Aptinyx Inc | APTX | NASDAQ | Common Stock |
| Price Change | Price Change % | Stock Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.0% | 0.42 | 00:17:29 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.42 |
| Trades | Stocks Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 2 | 21 | - | 0.20 - 3.7599 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 00:06:14 | 10 | US$ 0.4387 | USD |
Period:
Draw Mode:
Aptinyx Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| US$ 28.44M | 67.72M | 51.38M | US$ 1,000.00k | US$ - | -1.11 | -0.40 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | US$ - | - | - | 3.10% |
Aptinyx News
| Date | Time | Source | News Article |
|---|---|---|---|
| 06/1/2023 | 08:18 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 06/1/2023 | 08:17 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 12/12/2022 | 22:25 | TipRanks | H.C. Wainwright Keeps Their Buy Rating on Aptinyx (APTX) |
| 09/12/2022 | 08:06 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 02/12/2022 | 08:07 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 10/11/2022 | 23:45 | Business Wire | Preclinical Data from Aptinyx’s NMDA Receptor Modulators to.. |
| 10/11/2022 | 15:26 | TipRanks | SVB Securities Keeps Their Buy Rating on Aptinyx (APTX) |
| 10/11/2022 | 02:16 | TipRanks | BMO Capital Remains a Buy on Aptinyx (APTX) |
| 09/11/2022 | 08:32 | Edgar (US Regulatory) | Quarterly Report (10-q) |
| 09/11/2022 | 08:17 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 09/11/2022 | 08:05 | Business Wire | Aptinyx Reports Third Quarter 2022 Financial Results and.. |
| 03/11/2022 | 22:30 | Business Wire | Clinical Evaluation of Aptinyx's NYX-783 for Treatment of.. |
Historical APTX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.3907 | 0.45 | 0.3906 | 0.4128046 | 121,071 | 0.0293 | 7.5% |
| 1 Month | 0.2995 | 0.52 | 0.2995 | 0.4285334 | 284,424 | 0.1205 | 40.23% |
| 3 Months | 0.27 | 0.52 | 0.22 | 0.3389904 | 233,197 | 0.15 | 55.56% |
| 6 Months | 0.57 | 0.69 | 0.20 | 0.3698257 | 329,758 | -0.15 | -26.32% |
| 1 Year | 3.14 | 3.7599 | 0.20 | 0.8085308 | 343,781 | -2.72 | -86.62% |
| 3 Years | 4.06 | 6.47 | 0.20 | 2.87 | 491,572 | -3.64 | -89.66% |
| 5 Years | 17.40 | 32.25 | 0.20 | 3.95 | 399,734 | -16.98 | -97.59% |